clinical trial · NCT07066722
A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy Adults
ViiV Healthcare·phase1·completed·n = 126
HIV InfectionsVH4524184ItraconazoleRifabutinPhenytoinMetforminDigoxin
brief summary
The aim of the study is to gather information on how the drug behaves in healthy adults, how it is absorbed, and how it interacts when taken with other medicines.
started
Jul 7, 2025
primary completion
Dec 17, 2025
completion
Dec 17, 2025
last updated
Mar 9, 2026
official title
A Phase 1, Open-Label Study to Evaluate the Relative Bioavailability and the Effect of Food on VH4524184 Tablet Formulations, and to Evaluate the Potential for VH4524184 Drug-Drug-Interactions in Healthy Adult Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol